The ONCO/REVEAL High Sensitivity Lung Circulating Tumor DNA Panel is a targeted circulating free DNA (cfDNA)-based liquid biopsy solution for the sensitive detection of resistance or driver mutations from plasma samples. There is currently a large interest in using circulating tumor DNA detection in the bloodstream for treatment monitoring, for treatment sensitivity, as well as for its potential use for early detection. Unlike other assays on the market, the ONCO/REVEAL High Sensitivity Lung Circulating Tumor DNA Panel has a streamlined single-well processing approach, a very high on-target rate, and targets 17 known lung cancer oncogenes.
|Sample type||circulating free DNA (cfDNA)|
|DNA input||20 ng cfDNA|
|On target rate||93.2% ± 2.85%|
|Coverage uniformity||%>0.20 × Mean: 99.8% ± 0.7%
%>0.15 × Mean: 100.0% ± 0.0%